Your browser doesn't support javascript.
loading
Hyperbaric Oxygen Therapy as Adjuvant Treatment for Hardware-Related Infections in Neuromodulation.
Bartek, Jiri; Skyrman, Simon; Nekludov, Michael; Mathiesen, Tiit; Lind, Folke; Schechtmann, Gaston.
Afiliação
  • Bartek J; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
  • Skyrman S; Department of Clinical Neuroscience, Section for Neurosurgery, Karolinska Institutet, Stockholm, Sweden.
  • Nekludov M; Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Mathiesen T; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
  • Lind F; Section of Anesthesiology and Intensive Care, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Schechtmann G; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
Stereotact Funct Neurosurg ; 96(2): 100-107, 2018.
Article em En | MEDLINE | ID: mdl-29614489
ABSTRACT

BACKGROUND:

In neuromodulation therapies, hardware-related infections are a major challenge often leading to hardware removal.

OBJECTIVE:

To investigate the role of adjuvant hyperbaric oxygen therapy (HBOT) in hardware-related infections.

METHODS:

Fourteen hardware-related infection events in 12 consecutive patients between 2002 and 2015 were treated with antibiotics and adjuvant HBOT at the Karolinska University Hospital (Stockholm, Sweden). Two time-independent infection events related to hardware replacements occurred in 2 patients. Infection resolution and the need for hardware removal were assessed.

RESULTS:

Twelve out of 14 events of hardware-related infection were successfully treated without hardware removal (86%). The 2 patients treated twice with HBOT on 2 time-independent occasions could retain their hardware in both cases. Hardware was removed following HBOT failure in 2 infection events, with long-term infection control achieved in all patients. Further, an intrathecal pump malfunction caused by HBOT at 2.8 bars was observed, leading to a change in the manufacturer's guidelines.

CONCLUSIONS:

This study indicates a potential benefit of adjuvant HBOT in the treatment of hardware-related infections in neuromodulation, diminishing the need for hardware removal and treatment interruption. Prospective studies are warranted to establish the role of adjuvant HBOT in the treatment of hardware-related infections in neuromodulation.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Infecções Relacionadas à Prótese / Remoção de Dispositivo / Oxigenoterapia Hiperbárica / Antibacterianos Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Stereotact Funct Neurosurg Assunto da revista: NEUROCIRURGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Infecções Relacionadas à Prótese / Remoção de Dispositivo / Oxigenoterapia Hiperbárica / Antibacterianos Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Stereotact Funct Neurosurg Assunto da revista: NEUROCIRURGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suécia